145 related articles for article (PubMed ID: 8641761)
1. Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia.
Fagan PK; Djordjevic SP; Eamens GJ; Chin J; Walker MJ
Infect Immun; 1996 Mar; 64(3):1060-4. PubMed ID: 8641761
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.
Fagan PK; Walker MJ; Chin J; Eamens GJ; Djordjevic SP
Microb Pathog; 2001 Feb; 30(2):101-10. PubMed ID: 11162190
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF).
Fagan PK; Djordjevic SP; Chin J; Eamens GJ; Walker MJ
Infect Immun; 1997 Jun; 65(6):2502-7. PubMed ID: 9169801
[TBL] [Abstract][Full Text] [Related]
4. [Results of field studies using Stellamune mycoplasma vaccine in Luxembourg].
Schoos J
Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):43-50. PubMed ID: 9868832
[TBL] [Abstract][Full Text] [Related]
5. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
[TBL] [Abstract][Full Text] [Related]
7. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the gene encoding Mhp1 from Mycoplasma hyopneumoniae and examination of Mhp1's vaccine potential.
King KW; Faulds DH; Rosey EL; Yancey RJ
Vaccine; 1997 Jan; 15(1):25-35. PubMed ID: 9041663
[TBL] [Abstract][Full Text] [Related]
9. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
11. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia.
Kobisch M; Quillien L; Tillon JP; Wróblewski H
Ann Inst Pasteur Immunol; 1987; 138(5):693-705. PubMed ID: 3440060
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs.
Jensen CS; Ersbøll AK; Nielsen JP
Prev Vet Med; 2002 Jul; 54(3):265-78. PubMed ID: 12114013
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.
Thacker EL; Thacker BJ; Kuhn M; Hawkins PA; Waters WR
Am J Vet Res; 2000 Nov; 61(11):1384-9. PubMed ID: 11108184
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro comparisons of spray-drying and solvent- evaporation preparation of microencapsulated Mycoplasma hyopneumoniae for use as an orally administered vaccine for pigs.
Lin JH; Pan MJ; Liao CW; Weng CN
Am J Vet Res; 2002 Aug; 63(8):1118-23. PubMed ID: 12171164
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
16. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection.
Murphy D; Van Alstine WG; Clark LK; Albregts S; Knox K
Am J Vet Res; 1993 Nov; 54(11):1874-80. PubMed ID: 8291766
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method.
Lin JH; Weng CN; Liao CW; Yeh KS; Pan MJ
J Vet Med Sci; 2003 Jan; 65(1):69-74. PubMed ID: 12576707
[TBL] [Abstract][Full Text] [Related]
18. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine.
Shimoji Y; Oishi E; Muneta Y; Nosaka H; Mori Y
Vaccine; 2003 Jan; 21(5-6):532-7. PubMed ID: 12531653
[TBL] [Abstract][Full Text] [Related]
19. [Effect of the Stellamune Mycoplasma vaccine on growth, energy conversion, death, and medication use in fattening pigs on a pig farm chronically infected with Mycoplasma hyopneumoniae].
Bouwkamp FT; Elbers AR; Hunneman WA; Klaassen CH
Tijdschr Diergeneeskd; 2000 Jul; 125(14):444-8. PubMed ID: 10948597
[TBL] [Abstract][Full Text] [Related]
20. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
